相关实验视频

Updated: Jul 18, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

新辅助性SBRT与NSCLC的免疫疗法相结合:从机制到治疗

Yanhong Shi¹, Xiaoyan Ma², Dan He³

¹Department of Pathology, Xianyang Central Hospital, Xianyang, China.

Frontiers in immunology

|August 21, 2023

概括

新辅助免疫疗法在早期非小细胞肺癌 (NSCLC) 中表现有前途. 将其与立体性身体放射疗法 (SBRT) 结合起来,可以通过增强对瘤的免疫反应来改善患者的结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
辐射疗法辐射疗法

背景情况:

新辅助免疫疗法在早期切除的非小细胞肺癌 (NSCLC) 方面表现有前途.
需要新的组合疗法来提高患者的反应率.
立体性身体放射疗法 (SBRT) 可以刺激抗瘤免疫反应.

研究的目的:

审查SBRT与可切除NSCLC的新辅助免疫疗法相结合的机制.
确定这种组合治疗的最佳临床治疗策略.
讨论新辅助性SBRT和免疫治疗的临床前数据和临床试验.

主要方法:

临床前研究和临床试验的审查.
分析SBRT,瘤免疫微环境和全身免疫之间的相互作用.
讨论临床应用的最佳剂量,时间表和生物标志物.

主要成果:

SBRT增强了局部和全身抗瘤免疫反应.
联合治疗SBRT和免疫疗法抑制瘤生长并激活全身免疫力.
这种组合是切除性NSCLC的一个有希望的策略,有可能消除微转移.

结论:

将SBRT与新辅助免疫疗法结合起来,是切除性NSCLC的一个有希望的策略.
了解该机制为正在进行的临床试验提供了基础.
这种方法可能会为未来的临床应用带来更有效的治疗方案.

关键词:

生物标志物生物标志物免疫疗法免疫疗法新辅助疗法是一种新辅助疗法.其他非小细胞癌 (NSCLC)立体性身体辐射疗法 (SBRT)

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...